These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 28216417

  • 1. Expression Profiling of Clinical Specimens Supports the Existence of Neural Progenitor-Like Stem Cells in Basal Breast Cancers.
    Panaccione A, Guo Y, Yarbrough WG, Ivanov SV.
    Clin Breast Cancer; 2017 Jul; 17(4):298-306.e7. PubMed ID: 28216417
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic SOX10 gene signatures in salivary adenoid cystic and breast basal-like carcinomas.
    Ivanov SV, Panaccione A, Nonaka D, Prasad ML, Boyd KL, Brown B, Guo Y, Sewell A, Yarbrough WG.
    Br J Cancer; 2013 Jul 23; 109(2):444-51. PubMed ID: 23799842
    [Abstract] [Full Text] [Related]

  • 3. NOTCH1 and SOX10 are Essential for Proliferation and Radiation Resistance of Cancer Stem-Like Cells in Adenoid Cystic Carcinoma.
    Panaccione A, Chang MT, Carbone BE, Guo Y, Moskaluk CA, Virk RK, Chiriboga L, Prasad ML, Judson B, Mehra S, Yarbrough WG, Ivanov SV.
    Clin Cancer Res; 2016 Apr 15; 22(8):2083-95. PubMed ID: 27084744
    [Abstract] [Full Text] [Related]

  • 4. MYB fusions and CD markers as tools for authentication and purification of cancer stem cells from salivary adenoid cystic carcinoma.
    Panaccione A, Zhang Y, Ryan M, Moskaluk CA, Anderson KS, Yarbrough WG, Ivanov SV.
    Stem Cell Res; 2017 May 15; 21():160-166. PubMed ID: 28500913
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer.
    Joseph C, Arshad M, Kurozomi S, Althobiti M, Miligy IM, Al-Izzi S, Toss MS, Goh FQ, Johnston SJ, Martin SG, Ellis IO, Mongan NP, Green AR, Rakha EA.
    Breast Cancer Res Treat; 2019 Apr 15; 174(2):387-399. PubMed ID: 30554343
    [Abstract] [Full Text] [Related]

  • 6. The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells.
    Redmer T, Welte Y, Behrens D, Fichtner I, Przybilla D, Wruck W, Yaspo ML, Lehrach H, Schäfer R, Regenbrecht CR.
    PLoS One; 2014 Apr 15; 9(5):e92596. PubMed ID: 24799129
    [Abstract] [Full Text] [Related]

  • 7. Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme.
    Brown DV, Daniel PM, D'Abaco GM, Gogos A, Ng W, Morokoff AP, Mantamadiotis T.
    Oncotarget; 2015 Mar 20; 6(8):6267-80. PubMed ID: 25749043
    [Abstract] [Full Text] [Related]

  • 8. SRY-box transcription factor 10 is a highly specific biomarker of basal-like breast cancer.
    Klaric KA, Riaz N, Asleh K, Wang XQ, Atalla T, Strickland S, Nielsen TO, Kos Z.
    Histopathology; 2022 Feb 20; 80(3):589-597. PubMed ID: 34725848
    [Abstract] [Full Text] [Related]

  • 9. Salivary gland-like tumors of the breast express basal-type immunohistochemical markers.
    Reyes C, Jorda M, Gomez-Fernández C.
    Appl Immunohistochem Mol Morphol; 2013 Jul 20; 21(4):283-6. PubMed ID: 22935826
    [Abstract] [Full Text] [Related]

  • 10. CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancer.
    Sato T, Oshi M, Huang JL, Chida K, Roy AM, Endo I, Takabe K.
    Breast Cancer Res Treat; 2024 Nov 20; 208(2):415-427. PubMed ID: 39017815
    [Abstract] [Full Text] [Related]

  • 11. In vitro characterization of CD133lo cancer stem cells in Retinoblastoma Y79 cell line.
    Nair RM, Balla MM, Khan I, Kalathur RKR, Kondaiah P, Vemuganti GK.
    BMC Cancer; 2017 Nov 21; 17(1):779. PubMed ID: 29162051
    [Abstract] [Full Text] [Related]

  • 12. Clinicopathological, immunohistochemical and molecular correlation of neural crest transcription factor SOX10 expression in triple-negative breast carcinoma.
    Harbhajanka A, Chahar S, Miskimen K, Silverman P, Harris L, Williams N, Varadan V, Gilmore H.
    Hum Pathol; 2018 Oct 21; 80():163-169. PubMed ID: 29894722
    [Abstract] [Full Text] [Related]

  • 13. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL, Rowehl RA, Rivadeneira DE, Karpeh MS, Crawford H, Dufour A, Ju J, Wang Y, Leyfman Y, Botchkina GI.
    Cancer Genomics Proteomics; 2009 Oct 21; 6(1):19-29. PubMed ID: 19451087
    [Abstract] [Full Text] [Related]

  • 14. Differential expression of epithelial–mesenchymal transition and stem cell markers in intrinsic subtypes of breast cancer.
    Pomp V, Leo C, Mauracher A, Korol D, Guo W, Varga Z.
    Breast Cancer Res Treat; 2015 Nov 21; 154(1):45-55. PubMed ID: 26467042
    [Abstract] [Full Text] [Related]

  • 15. Dissecting the Origin of Breast Cancer Subtype Stem Cell and the Potential Mechanism of Malignant Transformation.
    Liu X, Feng D, Liu D, Wang S, Yu X, Dai E, Wang J, Wang L, Jiang W.
    PLoS One; 2016 Nov 21; 11(10):e0165001. PubMed ID: 27768723
    [Abstract] [Full Text] [Related]

  • 16. SOX10 expression in malignant melanoma, carcinoma, and normal tissues.
    Mohamed A, Gonzalez RS, Lawson D, Wang J, Cohen C.
    Appl Immunohistochem Mol Morphol; 2013 Dec 21; 21(6):506-10. PubMed ID: 23197006
    [Abstract] [Full Text] [Related]

  • 17. Impact of in vitro driven expression signatures of CD133 stem cell marker and tumor stroma on clinical outcomes in gastric cancers.
    Kim TM, Ko YH, Ha SJ, Lee HH.
    BMC Cancer; 2019 Feb 04; 19(1):119. PubMed ID: 30717708
    [Abstract] [Full Text] [Related]

  • 18. Analyzing mRNAsi-Related Genes Identifies Novel Prognostic Markers and Potential Drug Combination for Patients with Basal Breast Cancer.
    Huang K, Wu Y, Xie Y, Huang L, Liu H.
    Dis Markers; 2021 Feb 04; 2021():4731349. PubMed ID: 34646403
    [Abstract] [Full Text] [Related]

  • 19. CD133+ cancer stem-like cells promote migration and invasion of salivary adenoid cystic carcinoma by inducing vasculogenic mimicry formation.
    Wang SS, Gao XL, Liu X, Gao SY, Fan YL, Jiang YP, Ma XR, Jiang J, Feng H, Chen QM, Tang YJ, Tang YL, Liang XH.
    Oncotarget; 2016 May 17; 7(20):29051-62. PubMed ID: 27074560
    [Abstract] [Full Text] [Related]

  • 20. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.
    Rutella S, Bonanno G, Procoli A, Mariotti A, Corallo M, Prisco MG, Eramo A, Napoletano C, Gallo D, Perillo A, Nuti M, Pierelli L, Testa U, Scambia G, Ferrandina G.
    Clin Cancer Res; 2009 Jul 01; 15(13):4299-311. PubMed ID: 19509143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.